Table 2.
Baseline haemodynamic, cardio-respiratory fitness and fasting blood glucose data from before (week 0) and after (week 8) each intervention
| rIPC + Exercise | rIPC only | LMM | |||
|---|---|---|---|---|---|
| Week 0 | Week 8 | Week 0 | Week 8 | Condition | |
| MCAv (cm s−1) | 56 ± 10 | 57 ± 9 | 54 ± 14 | 53 ± 12 | 0.30 |
| PCAv (cm s−1) | 37 ± 3 | 36 ± 4 | 36 ± 3 | 36 ± 2 | 0.83 |
| PetCO2 (mmHg) | 38.5 ± 3.1 | 38.0 ± 3.7 | 41.6 ± 2.7 | 39.6 ± 3.5 | 0.35 |
| MAP (mmHg) | 99 ± 13 | 95 ± 11 | 102 ± 7 | 99 ± 5 | 0.45 |
| VO2peak (ml/kg/min) | 22.9 ± 5.4 | 25.7 ± 6.2 | 23.5 ± 2.9 | 23.6 ± 2.8 | 0.69 |
| Fasting blood glucose (mmol/L) | 5.9 ± 0.7 | 5.9 ± 0.7 | 6.4 ± 1.6 | 6.5 ± 1.4 | 0.27 |
Data presented as means ± SD
MCAv middle cerebral artery velocity, PCAv posterior cerebral artery velocity, PetCO2 partial pressure of end tidal carbon dioxide, MAP mean arterial pressure, rIPC remote ischaemic preconditioning, LMM linear mixed model